Evolution of the Average Target: UGI Corporation

Evolution of the Average Target - UGI Corporation

Evolution of the Target Price: UGI Corporation

Evolution of the Target Price - UGI Corporation

Changes in Analyst Recommendations: UGI Corporation

51.QRt522fFUdYPmHWr7MWBSEwKM1iuO-9ubK8gTSX90wE.MVIjrjK8PJ1X-zPMu7PEGAlLSmvmWZ8YX_lNCWO54jguQyOwDa0pkkPPMA~d39c2fc11f72e21d31426a9aab3845f0
29/09 Scotiabank Initiates UGI at Sector Outperform With $46 Price Target MT
14/09 Huntington Capital Initiates UGI at Outperform With $54 Price Target MT
10/09 UGI Shares Rise After Jefferies Upgrade MT
09/09 Jefferies Upgrades UGI to Buy From Hold, Adjusts Price Target to $43 From $40 MT
16/11/24 Mizuho Upgrades UGI to Outperform From Neutral, Adjusts Price Target to $30 From $27 MT
17/04/24 Mizuho Raises Price Target on UGI to $27 From $26, Keeps Neutral Rating MT
14/03/24 Wells Fargo Downgrades UGI to Equalweight From Overweight, Adjusts Price Target to $28 From $27 MT
19/01/24 Mizuho Adjusts UGI's Price Target to $26 From $29, Keeps Neutral Rating MT
11/09/23 Mizuho Securities Adjusts UGI Price Target to $29 From $33, Maintains Neutral Rating MT
28/08/23 Wells Fargo Upgrades UGI to Overweight From Equalweight, Trims Price Target to $27 From $28 MT
05/08/23 Wells Fargo Adjusts Price Target on UGI to $28 From $35, Maintains Equal-Weight Rating MT
18/04/23 Barclays Adjusts Price Target on UGI to $37 From $40, Maintains Underweight Rating MT
03/02/23 Barclays Adjusts Price Target on UGI to $40 From $39, Maintains Underweight Rating MT
19/01/23 Barclays Downgrades UGI to Underweight From Equalweight, Price Target is $39 MT
18/01/23 Analyst recommendations: Adobe, AstraZeneca, Morgan Stanley, Oracle... Zonebourse
11/01/23 Wells Fargo Adjusts Price Target on UGI to $42 From $41, Maintains Equal-Weight Rating MT
24/11/22 BofA Securities Downgrades UGI to Underperform From Neutral, Adjusts Price Target to $41 From $43 MT
22/11/22 Wells Fargo Adjusts Price Target on UGI to $39 From $36, Maintains Equal-Weight Rating MT
20/10/22 Barclays Trims UGI's Price Target to $36 From $40, Maintains Equalweight Rating MT
20/10/22 Wells Fargo Adjusts UGI's Price Target to $36 From $42, Reiterates Equalweight Rating MT
20/10/22 Barclays Adjusts UGI's Price Target to $36 From $40, Keeps Equalweight Rating MT
09/08/22 Wells Fargo Raises UGI's Price Target to $42 From $41, Maintains Equalweight Rating MT
29/04/22 Wells Fargo Adjusts UGI's Price Target to $40 from $46, Keeps Equalweight Rating MT
27/04/22 Janney Lowers Fair Value on UGI to $60 From $64, Maintains Buy Rating MT
23/03/22 Barclays Adjusts UGI's Price Target to $40 From $45, Keeps Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.37%
+5.95%
+9.26%
+12.26%
- +4.86%
+8.91%
-15.23%
+20.89%
Average +7.41%
Weighted average by Cap. +7.20%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
38.49USD
Average target price
43.25USD
Spread / Average Target
+12.37%
High Price Target
46.00USD
Spread / Highest target
+19.51%
Low Price Target
42.00USD
Spread / Lowest Target
+9.12%

Analyst Consensus Detail

Analyst consensus - UGI Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - UGI Corporation
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - UGI Corporation
  1. Stock Market
  2. Stocks
  3. UGI Stock
  4. Consensus UGI Corporation